People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NYX, Los Angeles Inc. | — | Other | Series A | $10.6M | $160.4M | 2010 |
| Xella Health, PBC | — | Biotechnology | Pre-Seed | $600K | $2.9M | 2024 |
Phillip Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Phillip Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jesus Ching | 1 | 2 |
| Christie Lee | 1 | 1 |
| James Bland | 1 | 1 |
| Carlos Signoret | 1 | 1 |
| Jourdi De Werd | 1 | 1 |
| Adriana Dantas Lemberg | 1 | 1 |
| Kelly Lacob | 1 | 1 |
| Toni Ko | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.